IdentificationGeneric Name(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanolDrugBank Accession NumberDB07761BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol (DB07761)× CloseWeightAverage: 415.4364 Monoisotopic: 415.181981415 Chemical FormulaC21H23F2N5O2SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUCyclin-dependent kinase 2Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableClassificationNot classifiedAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyZVSBKYYVBCKDBO-OAHLLOKOSA-NInChIInChI=1S/C21H23F2N5O2/c1-28(2)11-15(29)12-30-16-8-6-14(7-9-16)26-19-10-20(25-13-24-19)27-21-17(22)4-3-5-18(21)23/h3-10,13,15,29H,11-12H2,1-2H3,(H2,24,25,26,27)/t15-/m1/s1IUPAC Name(2R)-1-[4-({6-[(2,6-difluorophenyl)amino]pyrimidin-4-yl}amino)phenoxy]-3-(dimethylamino)propan-2-olSMILES[H]N(C1=CC=C(OC[C@H](O)CN(C)C)C=C1)C1=CC(=NC=N1)N([H])C1=C(F)C=CC=C1FReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound445951PubChem Substance99444232ChemSpider393431ZINCZINC000003581444PDBe LigandFCPPDB Entries1h00Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.036 mg/mLALOGPSlogP3.45ALOGPSlogP3.63ChemaxonlogS-4.1ALOGPSpKa (Strongest Acidic)12.42ChemaxonpKa (Strongest Basic)8.7ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count7ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area82.54 Å2ChemaxonRotatable Bond Count9ChemaxonRefractivity111.2 m3·mol-1ChemaxonPolarizability42.81 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.8404Blood Brain Barrier+0.5973Caco-2 permeable+0.5233P-glycoprotein substrateSubstrate0.686P-glycoprotein inhibitor INon-inhibitor0.6029P-glycoprotein inhibitor IIInhibitor0.9207Renal organic cation transporterNon-inhibitor0.7848CYP450 2C9 substrateNon-substrate0.8242CYP450 2D6 substrateNon-substrate0.7824CYP450 3A4 substrateSubstrate0.5201CYP450 1A2 substrateNon-inhibitor0.5085CYP450 2C9 inhibitorNon-inhibitor0.7862CYP450 2D6 inhibitorInhibitor0.6151CYP450 2C19 inhibitorNon-inhibitor0.5626CYP450 3A4 inhibitorNon-inhibitor0.6863CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.7241Ames testNon AMES toxic0.6329CarcinogenicityNon-carcinogens0.8637BiodegradationNot ready biodegradable1.0Rat acute toxicity2.4006 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9285hERG inhibition (predictor II)Inhibitor0.7274  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Cyclin-dependent kinase 2KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionMetal ion bindingSpecific FunctionSerine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, N...Gene NameCDK2Uniprot IDP24941Uniprot NameCyclin-dependent kinase 2Molecular Weight33929.215 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:25 / Updated at June 12, 2020 16:52 